Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir
Journal
Journal of the Formosan Medical Association
Journal Volume
116
Journal Issue
5
Pages
407-409
Date Issued
2017
SDGs
Other Subjects
alanine aminotransferase; alkaline phosphatase; aspartate aminotransferase; bilirubin; gamma glutamyltransferase; ledipasvir plus sofosbuvir; virus RNA; antivirus agent; benzimidazole derivative; fluorene derivative; ledipasvir, sofosbuvir drug combination; uridine phosphate; acute kidney failure; adult; alanine aminotransferase blood level; alkaline phosphatase blood level; antiviral therapy; aspartate aminotransferase blood level; bilirubin blood level; case report; cholestatic hepatitis; drug efficacy; gamma glutamyl transferase blood level; heart infarction; heart transplantation; hemodialysis; hepatic encephalopathy; hepatitis C; Hepatitis C virus; human; jaundice; Letter; liver transplantation; male; middle aged; oliguria; postoperative infection; sustained virologic response; acute kidney failure; analogs and derivatives; complication; heart failure; heart infarction; hepatic encephalopathy; hepatitis C; liver function test; pathophysiology; procedures; treatment outcome; Acute Kidney Injury; Antiviral Agents; Benzimidazoles; Fluorenes; Heart Failure; Heart Transplantation; Hepatic Encephalopathy; Hepatitis C; Humans; Liver Function Tests; Male; Middle Aged; Myocardial Infarction; Treatment Outcome; Uridine Monophosphate
Publisher
Elsevier B.V.
Type
letter